US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 1.410
  • +0.040+2.92%
Close May 17 16:00 ET
  • 1.410
  • -0.001-0.04%
Post 16:21 ET
58.58MMarket Cap-721P/E (TTM)

About Carisma Therapeutics Company

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in 2016 and is headquartered in Philadelphia, PA.

Company Profile

SymbolCARM
Company NameCarisma Therapeutics
Listing DateFeb 6, 2014
Founded2016
CEOMr. Steven Kelly
MarketNASDAQ
Employees107
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3675 Market Street,Suite 200
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104
Websitehttp://carismatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Steven Kelly
  • Director, President and Chief Executive Officer
  • 3.50M
  • Dr. Michael Klichinsky, PhD,Pharm.D.
  • Chief Scientific Officer
  • 1.60M
  • Richard S. Morris, C.P.A.
  • Chief Financial Officer
  • 1.66M
  • Sanford S. Zweifach
  • Chairman of the Board
  • 271.55K
  • Dr. Regina Hodits, PhD
  • Independent Director
  • --
  • Dr. John A. Hohneker, M.D.
  • Independent Director
  • --
  • Dr. Briggs W. Morrison, M.D.
  • Independent Director
  • 220.20K
  • Dr. Bjorn Odlander, M.D.,PhD
  • Independent Director
  • --
  • Michael P. Torok
  • Independent Director
  • 207.95K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg